Skip to Content

Dramatic improvement in 1-year survival for patients with acute promyelocytic leukemia

Clinical trials have reported rates of >95% durable remissions, but population studies from national registries report 1-year survival far below, namely at 70% and 5-year survival between 55 to 70%.

In this MEDtalk Anand P. Jillella, MD, from the Georgia Cancer Center at Augusta University, USA, explains how he and his colleagues succeeded with these dramatic improvements in 1-year survival for this group of patients.

Anand P. Jillella

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top